Posts Tagged ‘Healthcare’
dEEGtal awarded during the 18th HUG Innovation Day
Geneva University Hospitals (HUG) awarded the 2024 Innovation Prize to three projects: dEEGtal, an artificial intelligence-assisted biomarker for the early diagnosis of epilepsy; 3Dneointub8, a training device for nasotracheal intubation of infants; and Prestapp, a navigation aid for the healthcare network. As a bridge between the worlds of hospitals, universities and business, Innovation…
Read MorebNovate Technologies unveils new BactoSense product portfolio for advanced water quality monitoring
bNovate Technologies SA announced the launch of its new BactoSense product portfolio, featuring three innovative models: BactoSense CORE, BactoSense SMART and BactoSense PURE, and the new Active Cells – UV cartridge. The new versions of its automated analysers for online microbiological monitoring of water represent a significant advancement in water quality management, offering…
Read MoreE-health: The Sense and ZS join forces
The Sense, a Swiss-based academic research and innovation centre, is teaming up with ZS, an international firm renowned for its expertise in healthcare, analytics, technology and research, to revolutionise clinical research and e-health. Their collaboration will focus on validating digital devices and therapies for regulatory approval, as well as conducting real-life studies to…
Read MoredEEGtal receives CHF 10’000 from Venture Kick
dEEGtal, who is developing a software for epilepsy diagnosis, has received Venture Kick’s first financial and entrepreneurial support stage with CHF 10’000. The diagnosis of epilepsy is mostly based on visual interpretation of the electroencephalogram (EEG). This method inherently does not provide a diagnosis in 75-80% of the cases, making the diagnosis challenging,…
Read MoreExogems secures CHF 500K in seed-stage financing from business angels
Exogems secures CHF 500’000 in seed-stage financing from business angels to advance therapeutic exosome development. Exogems SA, a pioneering Swiss biotech company developing innovative therapeutic exosomes derived from microfragmented adipose tissue, today announced the successful completion of a CHF 500’000 fundraising round from business angels. This significant investment will fuel the company’s mission…
Read MoreSOPHIA DDM™ plateform certified under IVDR
SOPHiA GENETICS, the healthcare technology company and a global leader in data-driven medicine, announced that its SOPHiA DDM™ Platform is now CE marked under the European Union’s In Vitro Diagnostic Regulation (IVDR). IVDR certification is a significant regulatory milestone that validates the powerful analytical capabilities of the SOPHiA DDM™ Platform and allows customers…
Read MoreSamanTree Medical raises $14 Million in Series B financing round
SamanTree Medical, a leading medical technology company specialising in innovative solutions to improve the outcomes of surgery, announced the closing of $14 Million as part of a Series B financing round. The new capital will be used to further develop and commercialise the Histolog® Scanner, expand its reach in Europe and the United…
Read MoreNOA by biped marks successful market entry in Europe and the US
Navigation, Obstacle, Artificial intelligence (NOA) is the new brand name for biped’s AI mobility vest that can guide blind and visually impaired people. Following a successful market entry in ten countries, the company has signed three distribution partnerships to fie its US launch. Biped.ai specialises in innovative AI-powered navigation devices designed to enhance…
Read MoreCSEM develops a pioneering implant to support reproductive medicine
Swiss-based start-ups Impli and Yalosys, along with the technology innovation centre CSEM, announce a significant milestone in women’s healthcare—CERES. This implantable biosensor for real-time fertility hormone monitoring is now set to undergo a transformation that will make it ready for human trials by 2025. With Impli’s expertise, the biosensor has matured from a…
Read MoreThe Patient Quality of Life Challenge announced its finalists
Supported by Debiopharm, La-Solution.ch and the Inartis Foundation, the aim of this award is to support a selection of projects over a 4-month period to enable prototypes to be developed and produced. At the end of the year, the winner (or co-winners) whose prototype is judged to be the best will receive a prize of…
Read More